Understanding What is the Mechanism of Action of Afatinib?
•
3 min read
Afatinib is a second-generation tyrosine kinase inhibitor approved for specific non-small cell lung cancer (NSCLC) types. A key to its effectiveness lies in understanding **what is the mechanism of action of afatinib**—its irreversible inhibitory activity against multiple ErbB receptor family targets.
